Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
Of the millions of HTLV-1 infected carriers worldwide, 3–5% will develop an aggressive T-cell neoplasm that is highly refractory to conventional therapy. The virus carries the Tax oncogene which constitutively activates the NFκB pathway. This co-option of signaling through NFκB provides for the HTLV...
Main Authors: | Lee Ratner, Daniel A. Rauch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/3/6/886/ |
Similar Items
-
Mechanisms of Oncogenesis by HTLV-1 Tax
by: Suchitra Mohanty, et al.
Published: (2020-07-01) -
TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins
by: Stefania Fochi, et al.
Published: (2019-06-01) -
Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus
by: Mohadeseh Zarei Ghobadi, et al.
Published: (2023-03-01) -
PCBP1 interacts with the HTLV-1 Tax oncoprotein to potentiate NF-κB activation
by: Rui Su, et al.
Published: (2024-04-01) -
Blockade of LIRs as a new approach for diagnostics and treatment of ATLL malignancy
by: M. Keikha, et al.
Published: (2022-01-01)